HB 1333: Individualized Investigational Treatments
GENERAL BILL by Gerwig
Individualized Investigational Treatments ; Authorizes certain actions by eligible facilities, manufacturers operating within eligible facilities, & eligible patients relating to individualized investigational treatments; authorizes health plans, third-party administrators, & governmental agencies to provide coverage for cost of individualized investigational drug, biological product, or device, or cost of certain services; limits liability; prohibits licensing boards, disciplinary subcommittees, & entities responsible for Medicare certification from taking certain actions against health care provider's license; prohibits certain persons from blocking or attempting to block eligible patient's access to individualized investigational drug, biological product, or device; provides construction.
Last Action: 3/5/2025 House - Now in Health Professions & Programs Subcommittee
Bill Text: PDF
Bill History
| Date | Chamber | Action |
|---|---|---|
| 2/27/2025 | House |
• Filed |
| 3/4/2025 | House |
• 1st Reading (Original Filed Version) |
| 3/5/2025 | House |
• Referred to Health Professions & Programs Subcommittee • Referred to Budget Committee • Referred to Health & Human Services Committee • Now in Health Professions & Programs Subcommittee |
